PLoS ONENeurosciencePeer-reviewed journal article
Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Ass-coding region of App
Abstract
Model organisms mimicking the pathogenesis of human diseases are useful for identifying pathogenic mechanisms and testing therapeutic efficacy of compounds targeting them. Models of Alzheimers disease and related dementias aim to reproduce the brain pathology associated with these neurodegenerative disorders. Transgenic models, which involve random insertion of disease-causing genes under the control of artificial promoters, are efficient means of doing so. There are confounding factors associated with transgenic approaches, however, including target gene overexpression, dysregulation of endogenous gene expression at transgenes integration sites, and limitations in mimicking loss-of-function mechanisms. Furthermore, the choice of species is important, and there are anatomical, physiological, and cognitive reasons for favoring the rat over the mouse, which has been the standard for models of neurodegeneration and dementia. We report an initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in Long-Evans rats with humanizing mutations in the A{beta}-coding region of App, which encodes amyloid precursor protein (Apph/h rats), using the IntelliCage, an automated operant social home cage system, at 6-8 weeks of age, then again at 4-5 months of age. These rats were previously generated as control organisms for studies on neurodegeneration involving other knock-in rat models from our lab. Apph/h rats of either sex can acquire place learning and reversal tasks. They can also acquire a diagonal sequencing task by 6-8 weeks of age, but not a more advanced serial reversal task involving alternating diagonals, even by 4-5 months of age.
- Citations
- 6
- FWCI
- 0.93
- Field percentile
- top 29%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Generation of a hybrid AppNL-G-F/NL-G-F xThy1-GCaMP6s+/- Alzheimer disease mouse mitigates the behavioral and hippocampal encoding deficits of APP knock-in mutations of AppNL-G-F/NL-G-F mice
Samsoon Inayat, Brendan B. McAllister, … Majid H. Mohajerani·bioRxiv·Nov 18, 2022
- Motor deficits in the McGill-R-Thy1-APP transgenic rat model of Alzheimer's Disease
Kyle M. Roddick, Paige Northrup, … Richard E Brown·Behavioural ProcessesPeer-reviewed·Jan 17, 2026
- Amyloid-β seeding effects are dependent on the presence of knock-in genes in the AppNL-G-F mice.
S. G. Lacoursiere, D. Westaway, … R. J. Sutherland·bioRxiv·May 28, 2022
- Characterization of the knock-in AppSAA mouse model as a powerful tool for Alzheimer's disease preclinical research.
Lucy J. Sloan, Dylan T. Garceau, … Michael Sasner·bioRxiv·Sep 10, 2026
- APP-KI mice do not display the hallmark age-dependent cognitive decline of amyloid diseases
Lisa Blackmer‐Raynolds, Lyndsey D. Lipson, … Timothy Robert Sampson·bioRxiv·May 24, 2024
- New App knock-in mice that accumulate wild-type human Aβ as rapidly as AppNL-G-F mice exhibit intensive cored plaque pathology and neuroinflammation.
Kaori Sato, Naoto Watamura, … Hiroki Sasaguri·bioRxiv·Apr 30, 2021